Serena J. Silver
Accent Therapeutics (United States)(US)
Publications by Year
Research Areas
Protein Tyrosine Phosphatases, Science, Research, and Medicine, RNA and protein synthesis mechanisms, RNA Research and Splicing, RNA modifications and cancer
Most-Cited Works
- → Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1(2009)4,112 cited
- → A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles(2017)3,590 cited
- → The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors(2011)924 cited
- → Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy(2010)716 cited
- → Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening(2017)693 cited
- → CDK8 is a colorectal cancer oncogene that regulates β-catenin activity(2008)676 cited
- → A public genome-scale lentiviral expression library of human ORFs(2011)579 cited
- → Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells(2009)540 cited
- → Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning(2009)382 cited
- → An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia(2014)378 cited